title: The effect of intravitreal ranibizumab on intraoperative bleeding during pars plana vitrectomy for diabetic traction retinal detachment.
authors.forename: Jefferson A S
authors.initials: JA
authors.lastname: Ribeiro
authors.forename: André
authors.initials: A
authors.lastname: Messias
authors.forename: Felipe P P
authors.initials: FP
authors.lastname: de Almeida
authors.forename: Rogério A
authors.initials: RA
authors.lastname: Costa
authors.forename: Ingrid U
authors.initials: IU
authors.lastname: Scott
authors.forename: Lorena L
authors.initials: LL
authors.lastname: de Figueiredo-Pontes
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Jorge
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000150:complications* / Q000175:diagnosis; D005500:Follow-Up Studies; D006801:Humans; D007432:Intraoperative Period; D058449:Intravitreal Injections; D000069579:Ranibizumab; D012163:Retinal Detachment / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*; D016896:Treatment Outcome; D014821:Vitrectomy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab